Oragen Therapeutics
Besançon
About Oragen Therapeutics
Oragen Therapeutics pioneers oral genetic medicine for Inflammatory Bowel Diseases (IBD), including Crohn’s disease and ulcerative colitis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Mar 2025)
- Website: oragen-therapeutics.com
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oragen-therapeutics-2451580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.